Trace of a novel coronavirus pandemic that has spread from China
The American company Johnson & Johnson declared that its one-component vaccine against the novel coronavirus has demonstrated reliable protection against the delta strain, reports RIA Novosti.
“ Analysis of blood samples shows Johnson & Johnson vaccine induces delta neutralizing antibody appearance even at a higher level than against the “beta” variant; in South Africa, where the drug's high efficacy against the severe course of the disease has been demonstrated, '' & mdash; said in a statement.
It should be noted that the duration of the vaccine's immune response is at least eight months.
Previously, it was reported that scientists found the cause of blood clots & nbsp; in some people vaccinated against COVID. The drugs from AstraZeneca and Johnson & Johnson deliver the viral protein to the nucleus of a healthy cell, causing mutations that lead to side effects. & Nbsp;